Monday, November 9, 2026

USD/EUR Over 2% Down In The Last 21 Sessions

USD/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.42% for the last 21 sessions. At 17:11 EST on Sunday, 9 April, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 1.114% up from its 52-week low and 12.517% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.08%, a negative 0.12%, and a positive 0.46%, respectively.

USD/EUR's highest amplitude of average volatility was 0.55% (last week), 0.52% (last month), and 0.46% (last quarter), respectively.

News about

  • Usd/jpy surges to a 3-day high on sluggish US nonfarm payrolls report. According to FXStreet on Friday, 7 April, "On its way north, the USD/JPY cleared the R1 daily pivot point at 132.18 but fell short of testing the R2 pivot at 132.60. ", "A clear breach of the latter, and the USD/JPY could test April 4 133.16 daily high before challenging the R3 pivot at 133.31. "
  • According to FXStreet on Friday, 7 April, "Following the news, USD/JPY pares the previous day's rebound, down 0.10% around the intraday low of 131.61.", "It's worth noting that Good Friday holidays in major markets, except for Japan, allow the USD/JPY pair to remain active and consolidate recent gains while being on the way to posting a weekly loss."
  • Usd/jpy ignores yields to slip beneath 132.00 as Japan’s real wages drop at a slower pace, US NFP eyed. According to FXStreet on Friday, 7 April, "Above all, the divergence between the upbeat Japan data and disappointing US statistics keeps the USD/JPY pair on the bear's table. ", "Although the 50-DMA restricts immediate USD/JPY upside to around 133.15, USD/JPY bears need validation from an upward-sloping support line from mid-January, close to 131.30 by the press time."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com
USD/EUR Over 2% Down In The Last 21 Sessions | Via News